Numerous reports have demonstrated that exposure of ERα expressing breast cancer cells to estrogen results in increased rates of proliferation while more recent studies have suggested that expression of ERβ alone [21,24,25], or in combination with ERα [26-28], inhibits cell proliferation following estrogen exposure. This evidence concerns the gene ESR1 and breast cancer.